FDA warns of potential risk of liver injury in ADPKD patients taking Samsca
On Jan. 25, 2013, the U.S. Food and Drug Administration notified healthcare professionals of significant liver injury associated with the use of Samsca in…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.